Thoughts on HL RX 2025

Rising sophomore at semi-target/target with an interest in RX. My university has historically sent a few students to HL RX. Wondering the caliber of HL compared to other shops (PJT, EVR, MOE, etc.). What are the exits like? Is there any shot at MF or is it really just opportunistic credit/SS exits? Can I get into top business school later down the line with it? I am also wondering how the group weighs versus strong BB/EB M&A groups.

Any help is appreciated!

9 Comments
 
Most Helpful

Historically has been stronger, but still a tier 1/ tier 1.5 rx position. Would say below PJT/EVR and similar quality to Moe(although moe doesnt direct recruit rx so people would rather take the guaranteed rx spot at hl). Pretty comparable to EB M&A or top BB worse groups. People can exit from HL RX to a variety of UMM/MF funds, but there is more self selection on distressed funds bc you are likely getting more creditor exposure. 

This holds true for NY and to a lesser extent LA/CHI but as you get to the regional offices it will fall off.

 

Other EBs have caught up in North America but HL Rx still a fantastic offer. Wrt MFPE recruiting ppl have to realize that there are ~200 spots every class, which means ~2000-3000 candidates will be interviewed to fill those spots. HL Rx NY will definitely get you MFPE looks.

 

I'd put PJT RX/EVR RX in the same tier, then MOE/HL RX, and then LAZ RX (has fallen off)

 

Analyst 2 in IB - Cov:

I'd put PJT RX/EVR RX in the same tier, then MOE/HL RX, and then LAZ RX (has fallen off)


Depends on what you’re optimizing for. Purely mandates, maybe there’s some truth to this. Factoring exits, HL is at the bottom with next best MOE being a good bit above

 

HL RX (NYC) exits are excellent. Only teams with better exits would be the tippy top groups like PJT RSSG, EVR RX/M&A, GS TMT, MS M&A etc. I highly doubt MOE or LAZ has better exits (probably the same)

 

Vel ullam quo facere. Similique esse distinctio itaque eos officia veniam nemo. Dolores laudantium blanditiis sunt rerum minus.

Vel non sint voluptates dolor quis iste sequi. Omnis quo dolore fugiat dicta sed dolorum facilis dolor. Culpa nihil ea aut enim.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”